TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19860105

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Invasive mechanical ventilation (IMV)
Number of subjects: 156
Study: 16889454

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once daily)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 15219609

Group type: EXPERIMENTAL
Intervention: Auditory stimuli encoding
Number of subjects: 0
Study: 11485511

Group type: EXPERIMENTAL
Intervention: Combined continuous hormone replacement therapy (HRT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9926277

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.3-0.4 mg/daily)
Number of subjects: 58
Study: 7875640

Group type: EXPERIMENTAL
Intervention: Fasting conditions (300 mg oral dose of penticainide)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fed conditions (300 mg oral dose of penticainide)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fasting conditions (males)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fasting conditions (females)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fed conditions (males)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fed conditions (females)
Number of subjects: 16
Study: 2460520

Group type: EXPERIMENTAL
Intervention: 40% alcohol (100 ml intragastric administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 0
Study: 30987664

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h continuous infusion, reduced to 1 mg/kg/h in postanesthesia care unit)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 128
Study: 28238190

Group type: EXPERIMENTAL
Intervention: Resveratrol 40 mg/day
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Resveratrol 500 mg/day
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 26581881

Group type: EXPERIMENTAL
Intervention: Bio-inspired Artificial Pancreas (BiAP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bio-inspired Artificial Pancreas (BiAP) with all meals announced
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bio-inspired Artificial Pancreas (BiAP) with no or partial meal announcement
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard insulin pump therapy (open-loop)
Number of subjects: 12
Study: 23259919

Group type: EXPERIMENTAL
Intervention: Black currant anthocyanins (BCACs)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 38
Study: 21450590

Group type: EXPERIMENTAL
Intervention: Health Guide intervention
Number of subjects: 2664
Study: 18001688

Group type: EXPERIMENTAL
Intervention: Motion complexity (various complexities of moving stimuli)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference comparison interval (motionless stimuli)
Number of subjects: 0
Study: 16282436

Group type: EXPERIMENTAL
Intervention: GLU+FRUC (1.0 g/min of GLU + 0.5 g/min of FRUC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: GLU (1.5 g/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: WAT (water)
Number of subjects: 8
Study: 12669874

Group type: EXPERIMENTAL
Intervention: MTAD (mixture of a tetracycline isomer, an acid, and a detergent)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 5.25% sodium hypochlorite
Number of subjects: 48

Group type: COMPARATOR
Intervention: 17% EDTA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sterile distilled water
Number of subjects: 48
Study: 11916767

Group type: EXPERIMENTAL
Intervention: Calcium citrate malate and vitamin D supplementation
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 9641437

Group type: EXPERIMENTAL
Intervention: Fatigue group (experimental group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 7854793

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 13.5 mg t.d.s.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 27 mg t.d.s.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 19
Study: 2769578

Group type: EXPERIMENTAL
Intervention: Nutrition education program (four one-hour classes over two weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 877449

Group type: COMPARATOR
Intervention: Air at 28°C
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Xiphoid immersion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chest immersion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lower limb submergence
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Abdomen immersion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hip level immersion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Abdomen submergence
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Throughout the study
Number of subjects: 6
Study: 31507087

Group type: EXPERIMENTAL
Intervention: Weekend adherence
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Intervention adherence
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group adherence
Number of subjects: 136
Study: 31592976

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture (TA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-traditional acupuncture (NTA)
Number of subjects: 19
Study: 28029510

Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 26612290

Group type: EXPERIMENTAL
Intervention: Hamstring (HS) tendon autograft
Number of subjects: 106

Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone allograft
Number of subjects: 106
Study: 24034947

Group type: EXPERIMENTAL
Intervention: American cluster (more acculturated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bicultural cluster (more acculturated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SL‐ASIA summary score (one point increase)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asian cluster (less acculturated)
Number of subjects: 0
Study: 21562412

Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate (DP) 15 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Methylprednisolone acetate (MPA) 80 mg
Number of subjects: 60
Study: 18311844

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 40
Study: 17053536

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 15245

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 15245
Study: 14521705

Group type: EXPERIMENTAL
Intervention: 0.005% calcipotriol ointment applied twice a day
Number of subjects: 36

Group type: COMPARATOR
Intervention: 5% coal tar ointment applied overnight once daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.005% calcipotriol ointment
Number of subjects: 36

Group type: COMPARATOR
Intervention: 5% coal tar ointment
Number of subjects: 36
Study: 10930152

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) + Stavudine (d4T)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Didanosine (ddI) alone
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High dose ddI
Number of subjects: 78
Study: 9058316

Group type: EXPERIMENTAL
Intervention: low‐dose natural interferon‐alpha (nIFN alpha) for 6 months
Number of subjects: 237

Group type: COMPARATOR
Intervention: 6 cycles of maintenance chemotherapy (CAP)
Number of subjects: 237

Group type: COMPARATOR
Intervention: no maintenance therapy (control group)
Number of subjects: 237
Study: 8437528

Group type: EXPERIMENTAL
Intervention: Intravenous molsidomine (4 mg) on the first day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral molsidomine (4 mg) on the first day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral molsidomine (4 mg) on the second day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous molsidomine (4 mg) on the second day
Number of subjects: 10
Study: 30871518

Group type: EXPERIMENTAL
Intervention: NLP algorithm for identifying social isolation
Number of subjects: 4195
Study: 29509068

Group type: EXPERIMENTAL
Intervention: CS images
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: CS written message
Number of subjects: 160
Study: 27379388

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 58
Study: 24678983

Group type: EXPERIMENTAL
Intervention: Assessment of Chronic Illness Care (ACIC) survey
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Self-management Support (ACIC subscale)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Community Linkages (ACIC subscale)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Delivery System Design (ACIC subscale)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Organizational Support (ACIC subscale)
Number of subjects: 283
Study: 22563851

Group type: EXPERIMENTAL
Intervention: Repeated educational messages and consecutive two-month free trials with each of four POU products (n = 600)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group (n = 200)
Number of subjects: 800
Study: 20484968

Group type: EXPERIMENTAL
Intervention: Topical antioxidant pretreatment for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVA irradiation
Number of subjects: 0
Study: 18786346

Group type: EXPERIMENTAL
Intervention: Quad helix appliance
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion with an acrylic bonded appliance
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion after uprighting the upper molars with a Quad helix appliance
Number of subjects: 41
Study: 15818099

Group type: EXPERIMENTAL
Intervention: Thin computed tomography sections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thick computed tomography sections
Number of subjects: 30
Study: 12446164

Group type: EXPERIMENTAL
Intervention: Patients with pregnancy-related pain in the pelvis
Number of subjects: 9

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 9
Study: 10599726

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) infusion (1 microg/kg x h in saline)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CRH infusion
Number of subjects: 12
Study: 8951940

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine administration
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Epidural morphine administration
Number of subjects: 10
Study: 1929450

Group type: EXPERIMENTAL
Intervention: UFT 400 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: FT 600 mg/day
Number of subjects: 0
Study: 6358542

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837
Study: 30380116

Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 29040031

Group type: EXPERIMENTAL
Intervention: ATLG (20 mg/kg per day on days -3, -2, -1)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 27121596

Group type: EXPERIMENTAL
Intervention: Lovaza (3.36 g daily for 1 year)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no Lovaza)
Number of subjects: 6
Study: 24172159

Group type: EXPERIMENTAL
Intervention: Psychotropic medication use (lifetime and 12-month)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Anxiolytics
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Alternative medicines
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Antipsychotics
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Mood stabilizers
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Hypnotics
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Psychiatric case identification
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Age
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Marital status (being married)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Income
Number of subjects: 2000
Study: 21209073

Group type: EXPERIMENTAL
Intervention: Intramyocardial bone marrow cell injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19137353

Group type: COMPARATOR
Intervention: 20 mg triamcinolone acetonide (steroid group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5 mg sodium hyaluronate (hyaluronate group)
Number of subjects: 40
Study: 17311950

Group type: EXPERIMENTAL
Intervention: FeSO4
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Electrolytic iron
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Reduced iron
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Heme iron
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 15470872

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (GI)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Zinc phosphate (ZP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Resinous cement (RC)
Number of subjects: 14
Study: 11468606

Group type: EXPERIMENTAL
Intervention: Topical antibiotic ointment and occlusive patch over the affected eye (n=82)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Topical antibiotic ointment 4 times a day without an occlusive patch (n=81)
Number of subjects: 163
Study: 9571349

Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg/day)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Amlodipine (10 mg/day)
Number of subjects: 380
Study: 8149360

Group type: EXPERIMENTAL
Intervention: L-tyrosine (10 g/day in four divided doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-tyrosine
Number of subjects: 0
Study: 2907520

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-bunolol (2 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31084315

Group type: EXPERIMENTAL
Intervention: Regional Cerebral Perfusion (RCP)
Number of subjects: 549

Group type: COMPARATOR
Intervention: No Regional Cerebral Perfusion (No RCP)
Number of subjects: 549
Study: 28415907

Group type: EXPERIMENTAL
Intervention: TPM/oxycodone patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle patch
Number of subjects: 0
Study: 26121805

Group type: EXPERIMENTAL
Intervention: High-dose amino acid administration (4 ml x kg(‐1) x hr(‐1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose amino acid administration (2 ml x kg(‐1) x hr(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: No amino acid administration
Number of subjects: 30
Study: 23278295

Group type: EXPERIMENTAL
Intervention: Home-use irradiation group using an LED device (420-nm blue light and 660-nm red light for 2.5 min twice daily for 4 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group using a sham device
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Home-use irradiation group using an LED device
Number of subjects: 35
Study: 21681157

Group type: EXPERIMENTAL
Intervention: High glycemic index (GI) recovery diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low glycemic index (GI) recovery diet
Number of subjects: 10
Study: 19623014

Group type: EXPERIMENTAL
Intervention: siplizumab (0.012, 0.04, 0.12, or 0.4 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study: 16686912

Group type: EXPERIMENTAL
Intervention: Migraine group (14 subjects)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (19 subjects)
Number of subjects: 33
Study: 15111632

Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Palatal control device (PCD)
Number of subjects: 9
Study: 11702968

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 12
Study: 9041974

Group type: EXPERIMENTAL
Intervention: 3 mg salbutamol sulfate with 0.5 mg ipratropium bromide
Number of subjects: 342

Group type: COMPARATOR
Intervention: 3 mg salbutamol sulfate alone
Number of subjects: 342
Study: 7705095

Group type: EXPERIMENTAL
Intervention: CVR with 30 mcg EE
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CVR with 65 mcg EE
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CVR with 20 and 30 mcg EE
Number of subjects: 99

Group type: COMPARATOR
Intervention: NA/EE oral contraceptives
Number of subjects: 99

Group type: COMPARATOR
Intervention: EE/gestodene oral contraceptives
Number of subjects: 99
Study: 3063728

Group type: EXPERIMENTAL
Intervention: Carteolol
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nadolol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 63
Study: 31792304

Group type: EXPERIMENTAL
Intervention: Hormonal therapy + anti-HER2
Number of subjects: 6234

Group type: COMPARATOR
Intervention: Chemotherapy + anti-HER2
Number of subjects: 6234

Group type: COMPARATOR
Intervention: Hormonal therapy
Number of subjects: 6234

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 6234
Study: 30217193

Group type: EXPERIMENTAL
Intervention: Physical activity intervention programme (walking group of 120 min/week, supervised, for 9 months)
Number of subjects: 207
Study: 26912015

Group type: EXPERIMENTAL
Intervention: Peritoneal irrigation
Number of subjects: 81

Group type: COMPARATOR
Intervention: Suction alone
Number of subjects: 81
Study: 24641808

Group type: EXPERIMENTAL
Intervention: Personalized Cognitive Counseling (PCC) with rapid HIV testing
Number of subjects: 326

Group type: COMPARATOR
Intervention: Rapid HIV testing only
Number of subjects: 326
Study: 22610153

Group type: EXPERIMENTAL
Intervention: FEC-D (3 cycles of FEC100 followed by 3 cycles of 100 mg/m(2) docetaxel)
Number of subjects: 1999

Group type: COMPARATOR
Intervention: FEC (standard FEC100 for 6 cycles)
Number of subjects: 1999
Study: 20543022

Group type: EXPERIMENTAL
Intervention: Online fatigue self-management programme
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Information-only fatigue self-management programme
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Personal Wellbeing Index
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Physical Subscale of the Fatigue Impact Scale
Number of subjects: 95
Study: 17197223

Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement in osteoporosis group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement adjusted for age and BMI
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Speed of sound (SOS) measurement adjusted for BMD
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation (BUA) measurement
Number of subjects: 117
Study: 15572415

Group type: EXPERIMENTAL
Intervention: T enanthate, 200 mg im every 2 weeks, with placebo pills daily (T-only)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: T enanthate, 200 mg every 2 weeks, with 5 mg finasteride daily (T + F)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo injections and pills
Number of subjects: 70
Study: 12477979

Group type: EXPERIMENTAL
Intervention: Noncontact normothermic wound therapy (NNWT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard wound care (control)
Number of subjects: 40
Study: 10401944

Group type: EXPERIMENTAL
Intervention: Q.E.D. Alcohol Test A350 (saliva)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Blood samples (alcohol dehydrogenase method)
Number of subjects: 100
Study: 7781405

Group type: EXPERIMENTAL
Intervention: Chest X-ray screening with sputum cytologic study (intensive and regular rescreening)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest X-ray screening (annual)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest X-ray screening (less frequent rescreening)
Number of subjects: 0
Study: 2195517

Group type: EXPERIMENTAL
Intervention: Ultrashort-term prophylaxis for minor resections
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: One-day antibiotic prophylaxis for major resections
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group for minor resections (0 group)
Number of subjects: 200
Study: 397017

Group type: EXPERIMENTAL
Intervention: Lidoflazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lidoflazine and Physical training
Number of subjects: 24
Study: 30990260

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study: 28772310

Group type: EXPERIMENTAL
Intervention: Prototype questionnaire for self-assessment of ear disease risk
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group with age- or noise-related hearing loss
Number of subjects: 307
Study: 25908001

Group type: EXPERIMENTAL
Intervention: Standard-energy SLT treatment (270°)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sub-threshold energy SLT treatment (360°)
Number of subjects: 45
Study: 25168375

Group type: EXPERIMENTAL
Intervention: STAND-SIT condition (interchanging between standing and seated work posture every 30 min using an electric, height-adjustable workstation)
Number of subjects: 23

Group type: COMPARATOR
Intervention: SIT condition (seated work posture)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: STAND-SIT condition
Number of subjects: 23

Group type: COMPARATOR
Intervention: SIT condition
Number of subjects: 23
Study: 21402724

Group type: EXPERIMENTAL
Intervention: Wellness Recovery Action Planning (WRAP)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Usual care (wait-list control)
Number of subjects: 519